2月18日，银诺医药自主研发的依苏帕格鲁肽α注射液（商品名：怡诺轻）在阿里健康大药房首发上线。怡诺轻是一款人源超长效GLP-1（胰高血糖素样肽-1）药物，用于成人2型糖尿病治疗。 我国糖尿病患者数量庞大，成人糖尿病患者人数高达 1.48 ...

A small but significant new study showed low doses of Ozempic helped people to drink less. Scientists are starting to ...

Sweden's Ludvig Aberg is two shots back as leader Patrick Rodgers eyes a first PGA Tour win in 286 starts at the Genesis ...

Compared to the people who got a placebo, those who received Ozempic said they drank fewer drinks at home. They also drank ...

GLP-1的故事里，中国玩家终于又交上了新答卷。 最近，银诺医药自研的长效GLP-1药物依苏帕格鲁肽α注射液（商品名“怡诺轻”）获国家药监局批准上市，用于治疗成人2型糖尿病。2月11日，“怡诺轻”在线下公立医院开出了全国首张处方。 据悉，依苏帕格鲁肽α已经在京东健康、阿里健康两大电商平台开启预约，并将于2月18日正式首发，线上开售。 2021年左右，诺和诺德的司美格鲁肽“点燃”全球GLP-1市场之 ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

A once weekly injection of semaglutide, the main ingredient in Ozempic and Wegovy, may help problem drinkers kick their cravings.In a new study, the drug, known ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

Eli Lilly expects to read out results from a study in people with obesity and osteoarthritis of the knee in 2025.

American host and television producer Oprah Winfrey recently shared her initial experience of taking the weight loss drug GLP-1, touted to be a ‘magic drug.’ On her podcast, she expressed that it ...

They dive into the FDA’s recent approval of Ozempic for chronic kidney disease, the soaring costs of GLP-1 medications, and the growing influence of Mark Cuban’s Cost Plus Drug Company in ...